Moirai Biodesign’s General Shareholders Ordinary Meeting will be held on July, 18th, at 10:00h. Please find the agenda here. Please find the proxy here (english / spanish)More
Founded on the combination of cutting-edge synthetic biology and computational biology, Moirai Biodesign is putting RNA design at the service of biomedicine.
We envision our technologies and expertise as the catalysts of a healthcare ecosystem where rapid and affordable diagnostic methods are an option for all patients worldwide.